CUL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.633010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.377400E-01
Normal-vs-Stage2
1.490040E-01
Normal-vs-Stage3
7.136200E-02
Normal-vs-Stage4
8.677400E-01
Stage1-vs-Stage2
3.696800E-01
Stage1-vs-Stage3
2.512400E-02
Stage1-vs-Stage4
7.007000E-01
Stage2-vs-Stage3
8.00480015605842E-10
Stage2-vs-Stage4
1.838170E-01
Stage3-vs-Stage4
9.120300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.470410E-01
Normal-vs-AfricanAmerican
7.244200E-01
Normal-vs-Asian
7.929600E-02
Caucasian-vs-AfricanAmerican
1.602010E-01
Caucasian-vs-Asian
2.910000E-01
AfricanAmerican-vs-Asian
8.602400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.218360E-01
Normal-vs-Female
2.404000E-01
Male-vs-Female
3.074400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.458450E-01
Normal-vs-Age(41-60Yrs)
3.632800E-01
Normal-vs-Age(61-80Yrs)
1.202980E-01
Normal-vs-Age(81-100Yrs)
1.056620E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.682000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.116400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.353000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.798000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.273180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.392800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.142300E-02
Normal-vs-Daily Drinker
4.589500E-02
Normal-vs-Weekly Drinker
4.982000E-02
Normal-vs-Occasional Drinker
3.245200E-01
Normal-vs-Social Drinker
2.592800E-01
Non Drinker-vs-Daily Drinker
5.321800E-01
Non Drinker-vs-Weekly Drinker
6.267000E-01
Non Drinker-vs-Occasional Drinker
1.646380E-01
Non Drinker-vs-Social Drinker
2.944600E-01
Daily Drinker-vs-Weekly Drinker
9.473800E-01
Daily Drinker-vs-Occasional Drinker
7.900300E-02
Daily Drinker-vs-Social Drinker
1.495050E-01
Weekly Drinker-vs-Occasional Drinker
1.267990E-01
Weekly Drinker-vs-Social Drinker
2.057200E-01
Occasional Drinker-vs-Social Drinker
8.071000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.277800E-02
Normal-vs-Grade 2
1.459900E-02
Normal-vs-Grade 3
2.288200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.993000E-01
Grade 1-vs-Grade 3
2.391800E-01
Grade 1-vs-Grade 4
7.277800E-02
Grade 2-vs-Grade 3
1.408410E-01
Grade 2-vs-Grade 4
1.459900E-02
Grade 3-vs-Grade 4
2.288200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.341600E-02
Normal-vs-NonDiabetic
9.324000E-02
Diabetic-vs-NonDiabetic
1.811600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.255800E-02
Normal-vs-NoPancreatitis
9.043600E-02
Pancreatitis-vs-NoPancreatitis
5.146800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.008400E-01
Normal-vs-N1
1.692160E-01
N0-vs-N1
7.531600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.158000E-01
Normal-vs-TP53-NonMutant
4.361600E-01
TP53-Mutant-vs-TP53-NonMutant
9.229600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
